Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Becophos
- Development stage
- Unknown
- Lead developer
- TCF Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Intramuscular, Intravenous, Parenteral
01
Overview
Becophos is an approved injectable nutritional supplement developed by TCF Pharmaceuticals. It is formulated as a combination of Vitamin B-Complex and Vitamin B12, and is indicated for the treatment and prevention of nutritional deficiencies. The supplement helps replenish essential B vitamins, which are crucial for cellular metabolism, red blood cell production, and maintaining proper neurological function.
- Brand names
- BecophosBecophos Injection
- Other names
- Vitamin B complex + Vitamin B12Vitamin B-Complex + Vitamin B12Vitamin B-Complex with Vitamin B12
Beyond the preview
Go deeper on Becophos.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Becophos.